Gemma Brown - 26 Sep 2022 Form 4 Insider Report for Vaccitech plc (BRNS)

Role
Chief Financial Officer
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
BRNS
Transactions as of
26 Sep 2022
Net transactions value
$0
Form type
4
Filing time
28 Sep 2022, 16:05:16 UTC
Previous filing
23 Sep 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Award $0 +334,000 $0.000000 334,000 26 Sep 2022 Ordinary Shares 334,000 $3.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on September 15, 2023.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.